Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature

Ganciclovir (GCV)‐resistant cytomegalovirus (CMV) infection is a common problem among solid organ transplant (SOT) recipients without prior CMV immunity (CMV D+/R−). GCV‐resistant CMV represents a particular challenge for CMV management. Letermovir is a recently licensed antiviral agent for primary...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplant infectious disease 2021-06, Vol.23 (3), p.e13515-n/a
Hauptverfasser:	Hofmann, Eveline, Sidler, Daniel, Dahdal, Suzan, Bittel, Pascal, Suter‐Riniker, Franziska, Manuel, Oriol, Walti, Laura N., Hirzel, Cédric
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral drugs Bioavailability Cytomegalovirus Disease prevention Ganciclovir Hematopoietic stem cells human cytomegalovirus infection (CMV) Infections Kidney transplantation letermovir resistance Literature reviews Mutation Prophylaxis secondary CMV prophylaxis solid organ transplant Stem cell transplantation Stem cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!